InfuSystem Holdings, Inc.
AMEX:INFUMedical - Instruments & Supplies
+$0.35 today
- Market cap
- $281.67M
- Beta
- 1.42
- P/E (TTM)
- 23.2
- EPS (TTM)
- $0.39
Volume 0.19M
Average 0.16M
Income Statement
Follow revenue through to earnings.
Revenue
$143.44M
FY 2025 · Annual
+6.4% YoYOperating Income
$11.92M
FY 2025 · Annual
+73.0% YoYNet Income
$6.63M
FY 2025 · Annual
+182.6% YoYIncome Statement
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 102.38M | 109.91M | 125.79M | 134.86M | 143.44M |
| Cost of Revenue | 43.85M | 49.35M | 62.68M | 64.46M | 63.14M |
| Gross Profit | 58.54M | 60.56M | 63.11M | 70.4M | 80.3M |
| Gross Margin | 57.2% | 55.1% | 50.2% | 52.2% | 56.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 51.45M | 56.41M | 58.03M | 62.52M | 67.46M |
| Operating Expenses | 55.72M | 58.91M | 59.02M | 63.51M | 68.38M |
| Depreciation & Amortization | 14.63M | 13.36M | 12.51M | 12.5M | 13.29M |
| EBITDA | 17.26M | 14.89M | 16.53M | 20.03M | 25.22M |
| EBITDA Margin | 16.9% | 13.5% | 13.1% | 14.9% | 17.6% |
| Operating Income | 2.82M | 1.65M | 4.09M | 6.89M | 11.92M |
| Operating Margin | 2.8% | 1.5% | 3.2% | 5.1% | 8.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.38M | 1.4M | 2.17M | 1.78M | 1.3M |
| Other Income / Expenses | (1.56M) | (1.52M) | (2.24M) | (1.83M) | (1.3M) |
| Income Before Tax | 1.26M | 130K | 1.85M | 5.06M | 10.62M |
| Pre-Tax Margin | 1.2% | 0.1% | 1.5% | 3.8% | 7.4% |
| Income Tax Expense | (163K) | 112K | 979K | 2.71M | 4M |
| Net Income | 1.42M | 18K | 872K | 2.35M | 6.63M |
| Net Margin | 1.4% | 0.0% | 0.7% | 1.7% | 4.6% |
| EPS (Basic) | 0.07 | 0.00 | 0.04 | 0.11 | 0.32 |
| EPS (Diluted) | 0.06 | 0.00 | 0.04 | 0.11 | 0.31 |
| 20.52M | 20.65M | 21.02M | 21.27M | 20.66M | |
| 22.05M | 21.55M | 21.65M | 21.71M | 21.1M |
INFU Earnings Waterfall · TTM
AMEX:INFU · Revenue to Net Income
Key Ratios
Analysis
$142.4M of revenue converted into $7.9M of net income for the selected period. Gross margin is 56.8% and net margin is 5.5%, showing how much revenue survives after costs and taxes. EPS is $0.38, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| 8-K | Current report | Oct 27, 2026 |
How much revenue does INFU generate?
InfuSystem Holdings, Inc. (INFU) reported $143.44M of revenue in fiscal 2025.
Is INFU profitable?
InfuSystem Holdings, Inc. (INFU) reported $6.63M of net income, with a net margin of 4.6%.
Continue the stock analysis
Jump to another research area for this company.